Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2017
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2017   2016
Clinics open at beginning of period    
309
      
265
  
Opened or purchased during the period    
41
      
56
  
Acquired or sold during the period    
6
      
(6
 )
Closed or sold during the period    
(4
 )    
(6
 )
Clinics in operation at the end of the period    
352
      
309
  
    Year Ended
 December 31,
Company-owned or managed clinics:   2017   2016
Clinics open at beginning of period    
61
      
47
  
Opened during the period    
-
      
8
  
Acquired during the period    
-
      
6
  
Closed or sold during the period    
(14
 )    
-
  
Clinics in operation at the end of the period    
47
      
61
  
                 
Total clinics in operation at the end of the period    
399
      
370
  
                 
Clinics licenses sold but not yet developed    
104
      
115
  
Executed letters of intent for future clinic licenses    
8
      
-
  
Lease Exit Liability [Table Text Block]
Lease exit liability at December 31, 2016   $
338,151
  
Additions    
883,146
  
Settlements    
(891,991
 )
Net accretion    
(29,906
 )
Lease exit liability at December 31, 2017   $
299,400
  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
December 31,
    2017   2016
         
Net loss   $
(3,275,233
 )   $
(15,173,872
 )
                 
Weighted average common shares outstanding - basic    
13,245,119
      
12,696,649
  
Effect of dilutive securities:                
Stock options    
-
      
-
  
Weighted average common shares outstanding - diluted    
13,245,119
      
12,696,649
  
                 
Basic and diluted loss per share   $
(0.25
 )   $
(1.20
 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Year Ended
December 31,
    2017   2016
Unvested restricted stock    
63,700
      
92,415
  
Stock options    
1,003,916
      
953,075
  
Warrants    
90,000
      
90,000